Literature DB >> 2476775

Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator.

R N Fogoros1, J J Elson, C A Bonnet.   

Abstract

The actuarial incidence and pattern of occurrence of shocks were analyzed in 65 patients after implantation of the automatic implantable cardioverter defibrillator. During a mean follow-up of 25 +/- 21 months only one patient died suddenly, and this patient had a nonfunctioning device at the time of death. The long-term actuarial risk of death from any cause in the patients who received appropriate shocks was not significantly different than for the entire group. The 1- and 4-year cumulative risk of receiving any shock was 51 +/- 7% and 81 +/- 11%; of receiving an appropriate shock was 33 +/- 7% and 64 +/- 10%; of receiving a spurious shock was 17 +/- 5% and 21 +/- 6%; and of receiving an "indeterminate" shock was 19 +/- 6% and 52 +/- 10%. In 14 patients who were followed for 24 months without receiving an appropriate shock, the actuarial risk of receiving an appropriate shock was 29 +/- 14% during the next 24 months. The mean number of shocks delivered during appropriate episodes was 1.6 +/- 0.9, which was significantly lower than the mean of 4.0 +/- 2.0 shocks during spurious episodes (P less than 0.02). The mean number of shocks during indeterminate episodes was 1.7 +/- 1.5. Our data confirms the efficacy of the implantable defibrillator in preventing sudden death. The majority of patients with this device receive appropriate shocks during long-term follow-up, and the cumulative incidence of appropriate shocks increases steadily for at least 4 years. In contrast, the cumulative incidence of spurious shocks plateaus at about 12 months. Our data suggests that many "indeterminate" shocks actually appear to be appropriate.

Entities:  

Mesh:

Year:  1989        PMID: 2476775     DOI: 10.1111/j.1540-8159.1989.tb06151.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government.

Authors:  Kelley P Anderson
Journal:  J Interv Card Electrophysiol       Date:  2005-11       Impact factor: 1.900

2.  Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results.

Authors:  H F Pitschner; J Neuzner; E Himmrich; A Liebrich; J Jung; A Heisel
Journal:  J Interv Card Electrophysiol       Date:  1997-11       Impact factor: 1.900

Review 3.  Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete?

Authors:  R Cooley; M Akhtar; J Sra
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

4.  R-wave detection by subcutaneous ECG. Possible use for analyzing R-R variability.

Authors:  P Fotuhi; W Combs; C Condie; H Theres; T Schneider; K Stangl; G Baumann
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-01       Impact factor: 1.468

5.  Efficacy of a tiered therapy defibrillator system used to treat recurrent ventricular arrhythmias refractory to drugs.

Authors:  A C Rankin; S Zaim; A Powell; B Zaim; R Brooks; B A McGovern; H Garan; J N Ruskin
Journal:  Br Heart J       Date:  1993-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.